SUBSCRIBERS
Endofotonics raises S$12m in Series B funding, led by Singapore Medical Group
Published Fri, May 29, 2020 · 09:50 PM
Singapore
CANCER diagnostic company Endofotonics on Friday said it has raised S$12 million in a Series B round led by executives from locally listed healthcare company Singapore Medical Group.
The additional funding will be used to drive commercialisation of its early gastric cancer detection system in the Asia-Pacific, and to expand the coverage of its cancer detection technology to other organs.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
